Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
CAMBRIDGE, US: Genzyme Corporation has completed the sale of its pharmaceutical intermediates business to International Chemical Investors Group (ICIG). The ICIG purchased substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion. The acquired business has been renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma group platform of companies. Financial terms of the deal were not disclosed.
As part of the agreement, Corden Pharma entered into a supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease type 1 that is currently in phase 3 clinical trials. ICIG will also supply materials needed for the manufacture of other treatments, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. With this sale, Genzyme has completed the three divestitures announced last year as part of its effort to sharpen its focus on core businesses. In January the company completed the sale of its diagnostic products business, and in December it completed the sale of its genetic testing business.
© WOC News
Login
MIDLAND, US: The Dow Chemical Company recently said that it is launching a cash tender offer for approximately $ 750 million aggregate principal amo ...
NEW YORK, US: Dow Chemical Co, the largest US chemical maker, posted fourth-quarter earnings that rose more than analysts estimated amid increasing ...
MIDLAND, US/LONDON, UK/SHANDONG, CHINA: Davy Process Technology Limited (DPT) and The Dow Chemical Company’s (Dow) Oxygenated Solvents ...
PARIS, FRANCE: Total agreed with Silex Gas Norway AS, a wholly owned subsidiary of Allianz, to sell its entire stake in Gassled (6.4 per cent) ...
LYON, FRANCE: Rhodia invests in its cyclopentanone production unit, a move confirming its leading position in the fragrance markets. This major invest ...
Dow announced plans to fully integrate and grow North American performance businesses with shale gas liquids. MIDLAND, US: The Dow ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder